查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018836

聚乙醇酸市場：依形態、純度等級、分子量、應用和最終用途產業分類－2026-2032年全球市場預測

Polyglycolic Acid Market by Form, Purity Grade, Molecular Weight, Application, End Use Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，聚乙醇酸市場價值將達到 65.5 億美元，到 2026 年將成長至 72.1 億美元，到 2032 年將達到 127.5 億美元，複合年成長率為 9.97%。

主要市場統計數據
基準年 2025 65.5億美元
預計年份：2026年 72.1億美元
預測年份 2032 127.5億美元
複合年成長率 (%) 9.97%

聚乙醇酸的權威策略概述：涵蓋聚合物化學、製造注意事項和廣泛的應用趨勢。

聚乙醇酸(PGA) 是一種高性能可生物分解聚酯，其化學結構和水解特性使其成為需要瞬時機械強度和可預測吸水性的理想材料。 PGA 由Glico的開迴路聚合反應合成，具有高結晶質、拉伸強度和可控的水解特性，因此能夠控制分解速率，適用於多種應用。隨著材料科學的進步，對分子量、共聚物組成和加工條件的控制能力不斷提高，PGA 的應用範圍也從傳統的外科縫線擴展到藥物輸送系統、組織支架和特種包裝解決方案等領域。

材料、加工和監管方面的突破性變化重新定義了聚乙醇酸的應用開發和商業性競爭力。

隨著材料創新、監管重點和終端用戶期望的融合，聚乙醇酸）的價值創造途徑也隨之拓展，其市場格局正在演變。聚合物改質技術的進步，包括嵌段共聚和分子量分佈控制，拓展了PGA的功能範圍，使其分解曲線能夠進行精細調控，從而實現藥物釋放控制和組織再生。同時，精密纖維紡絲和積層製造等加工技術的進步提高了產品的可重複性，並實現了複雜形狀裝置的大規模生產。這些進展正在加速PGA的臨床應用和工業化推廣。

美國近期採取的關稅措施如何重塑了整個聚乙醇酸生態系統的供應鏈採購、成本結構和戰略投資決策。

美國2025年推出的定向關稅措施正在對聚酯和特殊聚合物的整個供應鏈產生影響，促使生產商、加工商和終端用戶重新評估其策略。上游中間體和成品聚合物進口關稅的提高推高了下游製造商的接收成本，並擠壓了依賴全球採購以維持生產連續性的下游製造商的利潤空間。因此，各公司的採購部門正在加快供應商網路多元化、選擇替代原料來源以及評估國內或近岸製造夥伴關係的步伐，以降低貿易政策波動帶來的風險。

基於細分市場的詳細洞察，展示了應用類型、外形尺寸、純度等級、分子量範圍和最終用途行業如何決定商業策略。

基於細分市場的洞察表明，應用主導的需求仍然是材料選擇和產品開發過程的核心。按應用領域分類，市場評估通常著重於藥物傳輸、包裝、外科縫線和組織工程。在包裝領域，重點進一步細分為食品包裝、工業包裝和藥品包裝，而組織工程研究則區分心臟修復和整形外科應用。這些應用差異導致了在水解穩定性、機械性能和監管依據等方面的規格差異，進而推動了獨特的配方和加工策略。

區域管理體制、製造能力和終端使用者需求模式如何塑造美洲、歐洲、中東和非洲以及亞太地區的差異化策略。

區域趨勢影響著聚乙醇酸的供應鏈結構、監管反應路徑和產品定位。在美洲，需求推動要素與醫療設備和先進包裝產業密切相關，這些產業需要嚴格的供應鏈管理和完善的品質系統。因此，該地區的製造商和加工商正在投資建造經過驗證的生產線和國內品質保證體系，以滿足臨床和食品接觸方面的要求。同時，擁有經驗豐富的聚合工程師以及與主要醫療設備製造商 (OEM) 地理位置上的接近性，有利於開展合作產品開發並加快產品上市速度。

競爭和策略方面的公司洞察揭示了純度控制、客製化能力和附加價值服務如何在 PGA 市場中創造永續的差異化優勢。

聚乙醇酸產業的競爭格局呈現出多種因素交織的特點，包括特種聚合物製造商、垂直整合供應商和應用型加工商。主要企業憑藉其保證醫用級產品純度、客製化分子量分佈以及為加工商提供檢驗的加工指導的能力而脫穎而出。聚合物製造商與醫療設備和包裝原始設備製造商 (OEM) 之間的策略合作日益普遍，透過聯合開發項目，可以加快認證流程，並確保材料與設備在無菌和儲存條件下的兼容性。

為製造商和相關人員提供切實可行的策略建議，以增強韌性、促進採用並在聚乙醇酸的應用中獲取價值。

產業領導企業應優先考慮一系列合作舉措，以保障利潤率並加速聚乙醇酸在高價值應用領域的普及。首先，他們應制定分階段的供應策略，將對醫用級產品的需求與工業級產品的供應分開。這將有助於在保持商業性柔軟性的同時，實現更有針對性的品管。同時，他們應投資於分子量控制和共聚物開發，以拓展產品功能，並開發獨特的配方，必要時可透過技術資料包和特定智慧財產權進行保護。

採用穩健的混合研究途徑，結合文獻整合、專家訪談、技術檢驗和供應鏈情境分析，確保提供實際的見解。

支持這些研究結果的調查方法結合了系統性的二手資料研究、有針對性的一手訪談和技術檢驗，以兼顧廣度和深度。二手資料研究涵蓋了同行評審文獻、監管指導文件和行業白皮書，以了解材料特性、最佳加工實踐和監管預期。一手訪談對象包括聚合物科學家、製程工程師、採購經理和法規遵循專家等代表性成員，旨在確定實際限制因素和應用促進因素。

明確的策略展望，整合了技術優勢、監管壓力和供應鏈優先事項，以指南聚乙醇酸相關人員在決策中採取下一步行動。

聚乙醇酸在先進生物材料和永續聚合物工程領域佔有戰略性地位。其優異的材料特性使其在醫療、藥物輸送和特殊包裝等領域具有卓越的應用前景，而加工技術和分子設計的最新創新也持續拓展其應用範圍。日益嚴格的法規、永續性發展的更高期望以及貿易政策的轉變，都要求企業制定靈活的商業策略，以平衡品質保證、成本競爭力和供應鏈韌性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：聚乙醇酸市場：依形式分類

  • 纖維
  • 電影
  • 座位

第9章：聚乙醇酸市場（依純度等級分類）

  • 工業級
  • 醫用級

第10章：聚乙醇酸市場（以分子量分類）

  • 高的
  • 低的
  • 中等的

第11章：聚乙醇酸市場：依應用領域分類

  • 藥物輸送
  • 包裝
    • 食品包裝
    • 工業包裝
    • 藥品包裝
  • 手術縫合線
  • 組織工程
    • 心臟修復
    • 整形外科應用

第12章：聚乙醇酸市場：依終端應用產業分類

  • 車
  • 醫療保健
  • 包裝
  • 纖維

第13章：聚乙醇酸市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：聚乙醇酸市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：聚乙醇酸市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國聚乙醇酸市場

第17章：中國聚乙醇酸市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aarti Industries Limited
  • Advanced Medical Solutions Group PLC
  • BMG Incorporated
  • Corbion NV
  • Daicel Corporation
  • Evonik Industries AG
  • Huizhou Foryou Medical Devices Co., Ltd.
  • Hu-Friedy Mfg. Co., LLC
  • Kureha Corporation
  • Lotus Surgicals Private Limited
  • Merck KGaA
  • Orion Sutures India Pvt. Ltd.
  • Samyang Holdings Corporation
  • Shenzhen Polymtek Biomaterial Co., Ltd.
  • SK Chemicals Co., Ltd.
  • Sumitomo Chemical Co., Ltd.
  • Synthomer plc
  • Teleflex Incorporated
  • Yulin Chemical Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Zhonglan Industry Co., Ltd.
Product Code: MRR-ED54C46E8D2A

The Polyglycolic Acid Market was valued at USD 6.55 billion in 2025 and is projected to grow to USD 7.21 billion in 2026, with a CAGR of 9.97%, reaching USD 12.75 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.55 billion
Estimated Year [2026] USD 7.21 billion
Forecast Year [2032] USD 12.75 billion
CAGR (%) 9.97%

An authoritative strategic overview of polyglycolic acid covering its polymer chemistry, manufacturing considerations, and broad application dynamics

Polyglycolic acid (PGA) is a high-performance biodegradable polyester whose chemical structure and hydrolytic properties make it a material of choice where temporary mechanical strength and predictable resorption are required. Synthesized through ring-opening polymerization of glycolide, PGA exhibits high crystallinity, tensile strength, and controlled hydrolysis that permit engineering of degradation kinetics for diverse applications. As material science advances, the ability to tailor molecular weight, copolymer composition, and processing conditions has broadened PGA's role from traditional surgical sutures into drug delivery systems, tissue scaffolds, and specialized packaging solutions.

The introduction of PGA in any commercial or clinical context demands an integrated understanding of raw material sourcing, polymer processing, and end-use performance requirements. Transitioning from lab-scale synthesis to industrial production involves managing thermal stability during extrusion and fiber spinning, ensuring consistent purity grade for medical uses, and implementing quality controls that satisfy regulatory expectations. Moreover, sustainability conversations increasingly frame biodegradable polymers as part of circular design strategies, which elevates the importance of feedstock selection, life-cycle impacts, and end-of-life pathways when positioning PGA for long-term adoption.

Transformative material, processing, and regulatory shifts that are redefining polyglycolic acid application development and commercial competitiveness

The landscape for polyglycolic acid is changing as material innovation, regulatory focus, and end-user expectations converge to create new routes to value. Advances in polymer modification, including block copolymerization and controlled molecular-weight distributions, have expanded the functional window of PGA, enabling finer tuning of degradation profiles for controlled drug release and tissue regeneration. Parallel developments in processing technologies-such as precision fiber spinning and additive manufacturing-have improved reproducibility and allowed complex device geometries to be realized at scale, which in turn accelerates clinical translation and industrial adoption.

At the same time, sustainability is reshaping competitive dynamics. Increased scrutiny of polymer life cycles has pushed manufacturers to explore greener feedstocks, improved reactor efficiency, and solvent-free processing wherever feasible. Regulatory frameworks are also shifting toward greater scrutiny of degradable polymers used in medical and food-contact applications; consequently, compliance-driven design and transparent traceability are no longer optional. Taken together, these transformative shifts favor vertically integrated players and agile specialist manufacturers that can deliver certified purity grades, responsive innovation pipelines, and demonstrable environmental credentials.

How recent United States tariff actions have reshaped supply chain sourcing, cost structures, and strategic investment decisions across the polyglycolic acid ecosystem

The introduction of targeted tariffs by the United States in 2025 has reverberated across polyesters and specialty polymers supply chains, prompting strategic reassessments among producers, converters, and end users. Increased import duties on upstream intermediates or finished polymer products raises landed costs and compresses margins for downstream manufacturers who rely on global procurement to maintain production continuity. As a result, corporate procurement teams have accelerated efforts to diversify supplier networks, qualify alternative feedstock sources, and evaluate domestic or nearshore manufacturing partnerships to mitigate exposure to trade policy volatility.

Beyond direct cost implications, the tariff environment has altered investment calculus for capacity expansion and innovation. Companies facing higher input costs are prioritizing capital allocation toward process efficiencies and material substitutions that reduce reliance on tariff-exposed imports. At the same time, long-term strategic responses include reshoring critical steps of production to shorten supply chains and strengthen quality control for medical-grade material. These shifts underscore the need for scenario-based planning that accounts for dynamic trade policies, cross-border logistics constraints, and the interplay between regulatory compliance and sourcing strategy.

Detailed segmentation-driven insights demonstrating how application types, form factors, purity grades, molecular weight ranges, and end-use industries determine commercial strategies

Segmentation-based insight reveals that application-driven requirements remain central to material selection and product development pathways. Based on Application, market evaluations typically address Drug Delivery, Packaging, Surgical Sutures, and Tissue Engineering; within Packaging the focus narrows to Food Packaging, Industrial Packaging, and Pharmaceutical Packaging, while Tissue Engineering investigations differentiate Cardiac Repair and Orthopedic Applications. These application distinctions translate to divergent specifications for hydrolytic stability, mechanical performance, and regulatory evidence, and thus drive bespoke formulation and processing strategies.

Form factors are equally pivotal because they govern downstream manufacturing and end-use integration. Based on Form, studies examine Fiber, Film, and Sheet formats, each associated with distinct processing windows, orientation-induced mechanical anisotropy, and sterilization constraints. End use industry orientation further refines development priorities. Based on End Use Industry, analyses consider Automotive, Medical, Packaging, and Textile contexts, revealing that medical applications demand the highest purity grades and documentation, while packaging and textile applications prioritize cost efficiency and process scalability.

Material quality classification and molecular architecture are the technical levers that enable these market-facing differentiations. Based on Purity Grade, distinctions between Industrial Grade and Medical Grade influence supplier qualification, analytical testing scope, and compliance pathways. Based on Molecular Weight, the High, Low, and Medium categories dictate polymer chain entanglement, tensile properties, and degradation timing, thereby informing decisions on extrusion parameters, sterilization approaches, and final product performance validation. Integrating these segmentation lenses helps stakeholders prioritize R&D investment, manufacturing optimization, and regulatory engagement to align product offerings with end-user value propositions.

How regional regulatory regimes, manufacturing capacities, and end-user demand patterns are shaping differentiated strategies across the Americas, EMEA, and Asia-Pacific

Regional dynamics shape supply chain architecture, regulatory pathways, and product positioning for polyglycolic acid. In the Americas, demand drivers are closely tied to the medical device and advanced packaging sectors, which require tight supply chain control and documented quality systems. This has prompted manufacturers and converters in the region to invest in validated manufacturing lines and in-country quality assurance capabilities to satisfy both clinical and food-contact requirements. Meanwhile, access to skilled polymer engineers and proximity to major device OEMs support collaborative product development and faster time-to-market.

Europe, Middle East & Africa presents a complex regulatory mosaic where material safety, biodegradability claims, and product stewardship are subject to divergent national policies and evolving supranational standards. Companies operating in this region must navigate stringent approval pathways for medical applications and heightened consumer expectations for sustainable packaging solutions, prompting stronger emphasis on traceability and environmental impact reporting. In the Asia-Pacific region, manufacturing scale and feedstock availability are significant advantages, and rapid expansion of medical device and packaging production capacity has driven investment in high-throughput processing technologies. However, variability in regulatory rigor across markets in the region requires careful alignment of material quality systems and localized compliance strategies to ensure consistent acceptance across jurisdictions.

Competitive and strategic company insights revealing how purity control, customization capabilities, and value-added services create sustainable differentiation in the PGA marketplace

Competitive dynamics in the polyglycolic acid space are characterized by a mix of specialty polymer producers, vertically integrated suppliers, and application-focused converters. Leading players differentiate on the basis of purity assurance for medical-grade products, customization of molecular-weight distributions, and the ability to provide validated processing guidance for converters. Strategic partnerships between polymer manufacturers and device or packaging OEMs are increasingly common, enabling co-development programs that accelerate qualification and ensure material-device compatibility under sterilization and storage conditions.

Technology differentiation also emerges from investments in process analytics, quality management systems, and certification programs that reduce regulatory friction for medical and pharmaceutical applications. Companies that offer comprehensive technical services-such as polymer characterization, sterilization validation support, and formulation advisory-tend to secure longer-term commercial relationships because they lower the barriers for customers to adopt novel material solutions. In parallel, strategic moves such as capacity expansion in low-cost production hubs or targeted acquisitions of specialty compounding assets are being used to balance cost competitiveness with high-margin medical offerings. Collectively, these approaches underscore the importance of aligning commercial strategy with demonstrable technical capabilities and supply-chain reliability.

Actionable strategic recommendations for manufacturers and stakeholders to build resilience, drive adoption, and capture value in polyglycolic acid applications

Industry leaders should prioritize a set of coordinated actions to protect margin and accelerate adoption of polyglycolic acid across high-value applications. First, develop a tiered supply strategy that separates commitments for medical-grade demand from industrial-grade volumes; this permits focused quality management while maintaining commercial flexibility. Concurrently, invest in molecular-weight control and copolymer development to expand functional performance and create proprietary formulations which can be defended by technical data packages and targeted IP where appropriate.

Second, strengthen supply chain resilience through supplier diversification, qualified nearshore options, and inventory strategies that account for trade-policy shocks. In parallel, embed lifecycle assessment and end-of-life planning into product roadmaps to support sustainability claims and regulatory reporting. Third, partner with converters and end users early in the development cycle to co-validate processing parameters and sterilization protocols, thereby shortening qualification timelines. Finally, align commercial and regulatory teams to produce robust technical dossiers that can accelerate market entry into medical, pharmaceutical, and food-contact segments, while using scenario planning to adapt capacity investment to evolving policy and demand signals.

A robust mixed-methods research approach combining literature synthesis, expert interviews, technical validation, and supply-chain scenario analysis to ensure actionable insight

The research methodology underpinning these insights combines systematic secondary review, targeted primary interviews, and technical validation to ensure both breadth and depth. Secondary research encompassed peer-reviewed literature, regulatory guidance documents, and industry white papers to map material properties, processing best practices, and regulatory expectations. Primary interviews were conducted with a representative mix of polymer scientists, process engineers, procurement leaders, and regulatory affairs specialists to capture real-world constraints and adoption drivers.

Technical validation involved cross-referencing reported performance metrics with independently published polymer characterization studies and with feedback from practicing device developers and converters. Supply chain mapping analyzed feedstock flows, manufacturing footprints, and logistics vulnerabilities to identify concentration risks. Finally, scenario analysis assessed potential outcomes from policy changes, production shifts, and technological innovations to provide decision-relevant perspectives. Limitations of the methodology include variability in proprietary process data and the evolving nature of regulatory guidance, which were mitigated through triangulation and sensitivity testing where feasible.

A conclusive strategic outlook that synthesizes technical strengths, regulatory pressures, and supply-chain priorities to inform next-step decisions for polyglycolic acid stakeholders

Polyglycolic acid occupies a strategic position at the intersection of advanced biomaterials and sustainable polymer engineering. Its material attributes enable performance-led applications in medicine, drug delivery, and specialized packaging, while recent innovations in processing and molecular design continue to widen its applicability. The confluence of regulatory rigor, sustainability expectations, and trade-policy shifts demands nimble commercial strategies that balance quality assurance with cost competitiveness and supply-chain resiliency.

Looking forward, stakeholders who invest in molecular customization, strengthen supplier networks, and proactively address life-cycle considerations will be best positioned to capture value as applications diversify. Cross-functional collaboration between R&D, manufacturing, regulatory, and commercial teams will accelerate qualification pathways and reduce time-to-adoption. Ultimately, success in this arena will depend on translating material science advantages into validated, scalable products that meet stringent performance and compliance requirements while responding to evolving policy and market signals.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Polyglycolic Acid Market, by Form

  • 8.1. Fiber
  • 8.2. Film
  • 8.3. Sheet

9. Polyglycolic Acid Market, by Purity Grade

  • 9.1. Industrial Grade
  • 9.2. Medical Grade

10. Polyglycolic Acid Market, by Molecular Weight

  • 10.1. High
  • 10.2. Low
  • 10.3. Medium

11. Polyglycolic Acid Market, by Application

  • 11.1. Drug Delivery
  • 11.2. Packaging
    • 11.2.1. Food Packaging
    • 11.2.2. Industrial Packaging
    • 11.2.3. Pharmaceutical Packaging
  • 11.3. Surgical Sutures
  • 11.4. Tissue Engineering
    • 11.4.1. Cardiac Repair
    • 11.4.2. Orthopedic Applications

12. Polyglycolic Acid Market, by End Use Industry

  • 12.1. Automotive
  • 12.2. Medical
  • 12.3. Packaging
  • 12.4. Textile

13. Polyglycolic Acid Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Polyglycolic Acid Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Polyglycolic Acid Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Polyglycolic Acid Market

17. China Polyglycolic Acid Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Aarti Industries Limited
  • 18.6. Advanced Medical Solutions Group PLC
  • 18.7. BMG Incorporated
  • 18.8. Corbion N.V.
  • 18.9. Daicel Corporation
  • 18.10. Evonik Industries AG
  • 18.11. Huizhou Foryou Medical Devices Co., Ltd.
  • 18.12. Hu-Friedy Mfg. Co., LLC
  • 18.13. Kureha Corporation
  • 18.14. Lotus Surgicals Private Limited
  • 18.15. Merck KGaA
  • 18.16. Orion Sutures India Pvt. Ltd.
  • 18.17. Samyang Holdings Corporation
  • 18.18. Shenzhen Polymtek Biomaterial Co., Ltd.
  • 18.19. SK Chemicals Co., Ltd.
  • 18.20. Sumitomo Chemical Co., Ltd.
  • 18.21. Synthomer plc
  • 18.22. Teleflex Incorporated
  • 18.23. Yulin Chemical Co., Ltd.
  • 18.24. Zhejiang Hisun Pharmaceutical Co., Ltd.
  • 18.25. Zhonglan Industry Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POLYGLYCOLIC ACID MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL POLYGLYCOLIC ACID MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES POLYGLYCOLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA POLYGLYCOLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FILM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FILM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FILM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY SHEET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY SHEET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY SHEET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY INDUSTRIAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY INDUSTRIAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MEDICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MEDICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY HIGH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY HIGH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY HIGH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY LOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY LOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY LOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MEDIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MEDIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MEDIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FOOD PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FOOD PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY FOOD PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY INDUSTRIAL PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY INDUSTRIAL PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY INDUSTRIAL PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PHARMACEUTICAL PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PHARMACEUTICAL PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PHARMACEUTICAL PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY SURGICAL SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY CARDIAC REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY CARDIAC REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY CARDIAC REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MEDICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MEDICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY MEDICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY TEXTILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY TEXTILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY TEXTILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS POLYGLYCOLIC ACID MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 148. GCC POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 150. GCC POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. GCC POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 152. GCC POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 153. GCC POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 170. G7 POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 172. G7 POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 174. G7 POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. G7 POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 176. G7 POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 177. G7 POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 178. NATO POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 180. NATO POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 182. NATO POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. NATO POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 184. NATO POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 185. NATO POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL POLYGLYCOLIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES POLYGLYCOLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA POLYGLYCOLIC ACID MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA POLYGLYCOLIC ACID MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA POLYGLYCOLIC ACID MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA POLYGLYCOLIC ACID MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA POLYGLYCOLIC ACID MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA POLYGLYCOLIC ACID MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA POLYGLYCOLIC ACID MARKET SIZE, BY TISSUE ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA POLYGLYCOLIC ACID MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)